Rank | Gene Set | Z-score |
---|---|---|
1 | negative T cell selection (GO:0043383) | 6.90889849 |
2 | negative thymic T cell selection (GO:0045060) | 6.46281875 |
3 | lysine catabolic process (GO:0006554) | 6.23930964 |
4 | lysine metabolic process (GO:0006553) | 6.23930964 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.15312440 |
6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.10098257 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.99153949 |
8 | negative regulation of cell killing (GO:0031342) | 5.99153949 |
9 | tricarboxylic acid cycle (GO:0006099) | 5.83885239 |
10 | positive T cell selection (GO:0043368) | 5.45777273 |
11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.40905052 |
12 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.29621218 |
13 | aspartate family amino acid catabolic process (GO:0009068) | 5.15588824 |
14 | positive regulation of granulocyte differentiation (GO:0030854) | 5.08974494 |
15 | 2-oxoglutarate metabolic process (GO:0006103) | 5.00332328 |
16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88626772 |
17 | NADH metabolic process (GO:0006734) | 4.82304654 |
18 | T cell selection (GO:0045058) | 4.77637862 |
19 | L-phenylalanine metabolic process (GO:0006558) | 4.76419800 |
20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.76419800 |
21 | regulation of gamma-delta T cell activation (GO:0046643) | 4.71791575 |
22 | fatty acid beta-oxidation (GO:0006635) | 4.70956910 |
23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.70290028 |
24 | L-phenylalanine catabolic process (GO:0006559) | 4.70290028 |
25 | glyoxylate metabolic process (GO:0046487) | 4.67573585 |
26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.65895356 |
27 | negative regulation of T cell mediated immunity (GO:0002710) | 4.64095281 |
28 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.57505218 |
29 | cysteine metabolic process (GO:0006534) | 4.48331901 |
30 | glycine metabolic process (GO:0006544) | 4.44877084 |
31 | response to interleukin-15 (GO:0070672) | 4.44104121 |
32 | regulation of regulatory T cell differentiation (GO:0045589) | 4.41658192 |
33 | thymic T cell selection (GO:0045061) | 4.40791145 |
34 | positive thymic T cell selection (GO:0045059) | 4.38399830 |
35 | cellular response to interleukin-15 (GO:0071350) | 4.38210521 |
36 | carnitine shuttle (GO:0006853) | 4.37555246 |
37 | tolerance induction (GO:0002507) | 4.37371638 |
38 | acetyl-CoA metabolic process (GO:0006084) | 4.36796110 |
39 | amino-acid betaine metabolic process (GO:0006577) | 4.35232689 |
40 | oxaloacetate metabolic process (GO:0006107) | 4.31395445 |
41 | branched-chain amino acid catabolic process (GO:0009083) | 4.28175068 |
42 | serine family amino acid catabolic process (GO:0009071) | 4.26229316 |
43 | fatty acid transmembrane transport (GO:1902001) | 4.22808780 |
44 | valine metabolic process (GO:0006573) | 4.21046696 |
45 | fatty acid oxidation (GO:0019395) | 4.20041057 |
46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.19737153 |
47 | T cell migration (GO:0072678) | 4.17963173 |
48 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.17529455 |
49 | fatty acid catabolic process (GO:0009062) | 4.15761386 |
50 | tricarboxylic acid metabolic process (GO:0072350) | 4.14880902 |
51 | lipid oxidation (GO:0034440) | 4.11296088 |
52 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.06976283 |
53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.06219602 |
54 | aromatic amino acid family catabolic process (GO:0009074) | 4.05187342 |
55 | short-chain fatty acid metabolic process (GO:0046459) | 4.03199730 |
56 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.03032079 |
57 | serine family amino acid metabolic process (GO:0009069) | 4.00782638 |
58 | kynurenine metabolic process (GO:0070189) | 4.00175624 |
59 | carnitine metabolic process (GO:0009437) | 3.98430330 |
60 | regulation of coenzyme metabolic process (GO:0051196) | 3.96068192 |
61 | regulation of cofactor metabolic process (GO:0051193) | 3.96068192 |
62 | serine family amino acid biosynthetic process (GO:0009070) | 3.95680150 |
63 | branched-chain amino acid metabolic process (GO:0009081) | 3.95588318 |
64 | cellular ketone body metabolic process (GO:0046950) | 3.94235868 |
65 | succinate metabolic process (GO:0006105) | 3.90306056 |
66 | alpha-beta T cell differentiation (GO:0046632) | 3.85951533 |
67 | interferon-gamma production (GO:0032609) | 3.85544546 |
68 | alpha-linolenic acid metabolic process (GO:0036109) | 3.82971087 |
69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.80271386 |
70 | monocarboxylic acid catabolic process (GO:0072329) | 3.79569339 |
71 | activated T cell proliferation (GO:0050798) | 3.76033814 |
72 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.75298618 |
73 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.74489096 |
74 | homocysteine metabolic process (GO:0050667) | 3.74260009 |
75 | biotin metabolic process (GO:0006768) | 3.73932595 |
76 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.72924555 |
77 | alpha-amino acid catabolic process (GO:1901606) | 3.72151638 |
78 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.71633185 |
79 | alpha-beta T cell activation (GO:0046631) | 3.70259948 |
80 | oxidative phosphorylation (GO:0006119) | 3.65120331 |
81 | carnitine transport (GO:0015879) | 3.63755195 |
82 | amino-acid betaine transport (GO:0015838) | 3.63755195 |
83 | T cell receptor signaling pathway (GO:0050852) | 3.59514935 |
84 | regulation of triglyceride catabolic process (GO:0010896) | 3.59396599 |
85 | carnitine transmembrane transport (GO:1902603) | 3.57898032 |
86 | regulation of fatty acid oxidation (GO:0046320) | 3.57868243 |
87 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.57817241 |
88 | regulation of sequestering of triglyceride (GO:0010889) | 3.57765337 |
89 | sulfur amino acid catabolic process (GO:0000098) | 3.56410754 |
90 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.54960058 |
91 | cellular amino acid catabolic process (GO:0009063) | 3.54087577 |
92 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.50798334 |
93 | leukocyte aggregation (GO:0070486) | 3.48270840 |
94 | ethanol oxidation (GO:0006069) | 3.48224622 |
95 | bile acid biosynthetic process (GO:0006699) | 3.48085922 |
96 | indolalkylamine catabolic process (GO:0046218) | 3.47729585 |
97 | tryptophan catabolic process (GO:0006569) | 3.47729585 |
98 | indole-containing compound catabolic process (GO:0042436) | 3.47729585 |
99 | organic acid catabolic process (GO:0016054) | 3.46501168 |
100 | carboxylic acid catabolic process (GO:0046395) | 3.46501168 |
101 | positive regulation of interleukin-2 production (GO:0032743) | 3.45280473 |
102 | positive regulation of tolerance induction (GO:0002645) | 3.40741417 |
103 | regulation of T cell tolerance induction (GO:0002664) | 3.39321501 |
104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.38901024 |
105 | fatty acid homeostasis (GO:0055089) | 3.38135712 |
106 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.37784014 |
107 | ketone body metabolic process (GO:1902224) | 3.37485262 |
108 | regulation of B cell differentiation (GO:0045577) | 3.35105846 |
109 | hepatocyte apoptotic process (GO:0097284) | 3.34116356 |
110 | tryptophan metabolic process (GO:0006568) | 3.32157103 |
111 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.31866112 |
112 | aspartate family amino acid metabolic process (GO:0009066) | 3.30079381 |
113 | B cell receptor signaling pathway (GO:0050853) | 3.29693846 |
114 | positive regulation of humoral immune response (GO:0002922) | 3.29618470 |
115 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.29537438 |
116 | T cell differentiation (GO:0030217) | 3.28124108 |
117 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.28112258 |
118 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.26915791 |
119 | mast cell activation (GO:0045576) | 3.25946315 |
120 | regulation of sulfur metabolic process (GO:0042762) | 3.25321323 |
121 | quaternary ammonium group transport (GO:0015697) | 3.25037344 |
122 | dicarboxylic acid metabolic process (GO:0043648) | 3.20706473 |
123 | urea cycle (GO:0000050) | 3.18844783 |
124 | urea metabolic process (GO:0019627) | 3.18844783 |
125 | histone mRNA catabolic process (GO:0071044) | 3.18119703 |
126 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.17419753 |
127 | L-serine metabolic process (GO:0006563) | 3.16851734 |
128 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.16323228 |
129 | glutamate metabolic process (GO:0006536) | 3.15272936 |
130 | regulation of granulocyte differentiation (GO:0030852) | 3.15270108 |
131 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.15163635 |
132 | coenzyme catabolic process (GO:0009109) | 3.14706347 |
133 | cellular modified amino acid catabolic process (GO:0042219) | 3.14680793 |
134 | positive regulation of fatty acid oxidation (GO:0046321) | 3.11865015 |
135 | sarcomere organization (GO:0045214) | 3.11222642 |
136 | NAD metabolic process (GO:0019674) | 3.10534760 |
137 | folic acid metabolic process (GO:0046655) | 3.08842334 |
138 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.08140744 |
139 | positive regulation of B cell differentiation (GO:0045579) | 3.07922196 |
140 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.07649775 |
141 | aromatic amino acid family metabolic process (GO:0009072) | 3.04787450 |
142 | nitrogen cycle metabolic process (GO:0071941) | 3.04461183 |
143 | negative regulation of adaptive immune response (GO:0002820) | 3.01584257 |
144 | negative regulation of B cell proliferation (GO:0030889) | 2.99106105 |
145 | T cell homeostasis (GO:0043029) | 2.97761427 |
146 | negative regulation of T cell apoptotic process (GO:0070233) | 2.97409508 |
147 | lymph node development (GO:0048535) | 2.97295692 |
148 | acylglycerol homeostasis (GO:0055090) | 2.96735987 |
149 | triglyceride homeostasis (GO:0070328) | 2.96735987 |
150 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.94189180 |
151 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.94155593 |
152 | ATP synthesis coupled proton transport (GO:0015986) | 2.94155593 |
153 | mast cell activation involved in immune response (GO:0002279) | 2.94095709 |
154 | mast cell degranulation (GO:0043303) | 2.94095709 |
155 | regulation of tolerance induction (GO:0002643) | 2.93993649 |
156 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.93488193 |
157 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.92221625 |
158 | respiratory electron transport chain (GO:0022904) | 2.91136356 |
159 | bile acid metabolic process (GO:0008206) | 2.90240691 |
160 | negative regulation of fibrinolysis (GO:0051918) | 2.89847727 |
161 | one-carbon metabolic process (GO:0006730) | 2.89768121 |
162 | acyl-CoA metabolic process (GO:0006637) | 2.88785365 |
163 | thioester metabolic process (GO:0035383) | 2.88785365 |
164 | drug transmembrane transport (GO:0006855) | 2.88003665 |
165 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.87970446 |
166 | 4-hydroxyproline metabolic process (GO:0019471) | 2.86732292 |
167 | positive regulation of interleukin-4 production (GO:0032753) | 2.82442354 |
168 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.81818623 |
169 | regulation of alpha-beta T cell activation (GO:0046634) | 2.80072000 |
170 | dosage compensation (GO:0007549) | 2.79280536 |
171 | histone H3-K36 demethylation (GO:0070544) | 2.77025315 |
172 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.73400532 |
173 | positive regulation of isotype switching (GO:0045830) | 2.72071122 |
174 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.70789441 |
175 | histone-serine phosphorylation (GO:0035404) | 2.69923912 |
176 | T cell activation (GO:0042110) | 2.69682469 |
177 | T-helper cell differentiation (GO:0042093) | 2.68306902 |
178 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.68306902 |
179 | natural killer cell differentiation (GO:0001779) | 2.68062110 |
180 | V(D)J recombination (GO:0033151) | 2.67477745 |
181 | negative regulation of B cell mediated immunity (GO:0002713) | 2.64326550 |
182 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.64326550 |
183 | positive regulation of T cell cytokine production (GO:0002726) | 2.64141117 |
184 | nuclear pore complex assembly (GO:0051292) | 2.60861347 |
185 | regulation of T cell mediated immunity (GO:0002709) | 2.60469530 |
186 | establishment of protein localization to Golgi (GO:0072600) | 2.60375320 |
187 | protein K63-linked deubiquitination (GO:0070536) | 2.60109546 |
188 | positive regulation of T cell mediated immunity (GO:0002711) | 2.57483261 |
189 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.56652457 |
190 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.55844566 |
191 | positive regulation of DNA recombination (GO:0045911) | 2.53959889 |
192 | regulation of interleukin-2 production (GO:0032663) | 2.53656976 |
193 | dendritic cell migration (GO:0036336) | 2.52903485 |
194 | myeloid dendritic cell activation (GO:0001773) | 2.51566898 |
195 | dendritic cell chemotaxis (GO:0002407) | 2.51227806 |
196 | peptidyl-lysine trimethylation (GO:0018023) | 2.51190017 |
197 | protein K48-linked deubiquitination (GO:0071108) | 2.50144789 |
198 | protein targeting to Golgi (GO:0000042) | 2.49567740 |
199 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.49407181 |
200 | rRNA catabolic process (GO:0016075) | 2.48229863 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.54217048 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.44890707 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.43319306 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.39642880 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.22092824 |
6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.00258755 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.90222578 |
8 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.54420584 |
9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.33608688 |
10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.33130294 |
11 | MYB_26560356_Chip-Seq_TH2_Human | 3.25388128 |
12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.25268340 |
13 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.22325553 |
14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.11698142 |
15 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.02516976 |
16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.98341681 |
17 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.85836952 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.85816847 |
19 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.56615265 |
20 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.53216885 |
21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52053055 |
22 | MYB_26560356_Chip-Seq_TH1_Human | 2.50622655 |
23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.48699824 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.47652047 |
25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40498110 |
26 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38202409 |
27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.34302193 |
28 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.34015889 |
29 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.22861616 |
30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22172007 |
31 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.13897293 |
32 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.11685611 |
33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.08625157 |
34 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.05861700 |
35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.05258167 |
36 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.04407665 |
37 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.03236423 |
38 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.02147382 |
39 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.01200803 |
40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.98689673 |
41 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.93764081 |
42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.92386833 |
43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.89786954 |
44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.88762538 |
45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.88584824 |
46 | MAF_26560356_Chip-Seq_TH1_Human | 1.87349166 |
47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.86797232 |
48 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.86459530 |
49 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85100396 |
50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81339618 |
51 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79230847 |
52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78825790 |
53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.76425428 |
54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75438860 |
55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75317748 |
56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.73446045 |
57 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.72135653 |
58 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.65762197 |
59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.64557943 |
60 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61777337 |
61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60611445 |
62 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60206727 |
63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.59551390 |
64 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59059134 |
65 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.58622835 |
66 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.56702286 |
67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56490049 |
68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.56149540 |
69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55013131 |
70 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51023068 |
71 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.50411870 |
72 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.48915824 |
73 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48344589 |
74 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47204666 |
75 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.46892366 |
76 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45248705 |
77 | MAF_26560356_Chip-Seq_TH2_Human | 1.44812291 |
78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43366860 |
79 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.43028583 |
80 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40602854 |
81 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40589556 |
82 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.40272627 |
83 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39847856 |
84 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.37694359 |
85 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37550968 |
86 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.36329537 |
87 | MYC_22102868_ChIP-Seq_BL_Human | 1.35937617 |
88 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35304112 |
89 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34771669 |
90 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.33121733 |
91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30425159 |
92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.30305134 |
93 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.29929121 |
94 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26921761 |
95 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26479204 |
96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25620541 |
97 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.24550079 |
98 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.18655954 |
99 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18535625 |
100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16005901 |
101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.14706036 |
102 | GATA3_26560356_Chip-Seq_TH1_Human | 1.10389713 |
103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.09762857 |
104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06088558 |
105 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06002115 |
106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.05162759 |
107 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04710109 |
108 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03689493 |
109 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.03494286 |
110 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03126755 |
111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02783210 |
112 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02707853 |
113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01533101 |
114 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01434216 |
115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.01331933 |
116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00671140 |
117 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.99512177 |
118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98407799 |
119 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97062635 |
120 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96834665 |
121 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96063142 |
122 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.95154079 |
123 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94465717 |
124 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.94074486 |
125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93770386 |
126 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.93631232 |
127 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93588482 |
128 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93497576 |
129 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93297694 |
130 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.93050149 |
131 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.92534210 |
132 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92171795 |
133 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91871957 |
134 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.90443302 |
135 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89710712 |
136 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89441560 |
137 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89150559 |
138 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.89111825 |
139 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.88853192 |
140 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86905261 |
141 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86088163 |
142 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.85594040 |
143 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84272947 |
144 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.84068468 |
145 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.83943176 |
146 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.83485351 |
147 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.83381663 |
148 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83113547 |
149 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83015348 |
150 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.82726683 |
151 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82308078 |
152 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.81979049 |
153 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.81798567 |
154 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81736952 |
155 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81700783 |
156 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80376137 |
157 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.79311686 |
158 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.78725147 |
159 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.78417708 |
160 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.77861511 |
161 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77749883 |
162 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77748708 |
163 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77748708 |
164 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.77300047 |
165 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.75959031 |
166 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75868754 |
167 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.75792787 |
168 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75764021 |
169 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.72362145 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003763_abnormal_thymus_physiology | 5.16720572 |
2 | MP0002139_abnormal_hepatobiliary_system | 5.04876626 |
3 | MP0005360_urolithiasis | 4.93276014 |
4 | MP0003806_abnormal_nucleotide_metabolis | 4.68640517 |
5 | MP0005085_abnormal_gallbladder_physiolo | 4.11368986 |
6 | MP0002837_dystrophic_cardiac_calcinosis | 4.06295548 |
7 | MP0005365_abnormal_bile_salt | 3.92444067 |
8 | MP0005671_abnormal_response_to | 3.84147696 |
9 | MP0003646_muscle_fatigue | 3.80208499 |
10 | MP0008057_abnormal_DNA_replication | 3.27679705 |
11 | MP0001835_abnormal_antigen_presentation | 3.02802896 |
12 | MP0004084_abnormal_cardiac_muscle | 3.01073577 |
13 | MP0001800_abnormal_humoral_immune | 2.91720816 |
14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.80943434 |
15 | MP0006036_abnormal_mitochondrial_physio | 2.72282859 |
16 | MP0005332_abnormal_amino_acid | 2.61534807 |
17 | MP0000703_abnormal_thymus_morphology | 2.59921913 |
18 | MP0003724_increased_susceptibility_to | 2.57261881 |
19 | MP0002009_preneoplasia | 2.44534576 |
20 | MP0004215_abnormal_myocardial_fiber | 2.44062639 |
21 | MP0005330_cardiomyopathy | 2.43296975 |
22 | MP0002398_abnormal_bone_marrow | 2.40543581 |
23 | MP0005000_abnormal_immune_tolerance | 2.38860807 |
24 | MP0003436_decreased_susceptibility_to | 2.38187574 |
25 | MP0010329_abnormal_lipoprotein_level | 2.36709196 |
26 | MP0003252_abnormal_bile_duct | 2.36338084 |
27 | MP0002723_abnormal_immune_serum | 2.35261297 |
28 | MP0002420_abnormal_adaptive_immunity | 2.32393131 |
29 | MP0001819_abnormal_immune_cell | 2.30852220 |
30 | MP0001873_stomach_inflammation | 2.25404014 |
31 | MP0004130_abnormal_muscle_cell | 2.23938276 |
32 | MP0004381_abnormal_hair_follicle | 2.23439909 |
33 | MP0009840_abnormal_foam_cell | 2.18032872 |
34 | MP0009333_abnormal_splenocyte_physiolog | 2.17189782 |
35 | MP0002452_abnormal_antigen_presenting | 2.16079655 |
36 | MP0000751_myopathy | 2.15476848 |
37 | MP0004036_abnormal_muscle_relaxation | 2.14811838 |
38 | MP0005670_abnormal_white_adipose | 2.10834124 |
39 | MP0003195_calcinosis | 2.10204226 |
40 | MP0000689_abnormal_spleen_morphology | 2.10052164 |
41 | MP0000716_abnormal_immune_system | 2.08849436 |
42 | MP0002166_altered_tumor_susceptibility | 2.08659916 |
43 | MP0005075_abnormal_melanosome_morpholog | 2.04866604 |
44 | MP0002722_abnormal_immune_system | 2.03385306 |
45 | MP0000569_abnormal_digit_pigmentation | 2.02192205 |
46 | MP0003866_abnormal_defecation | 2.01337715 |
47 | MP0009785_altered_susceptibility_to | 1.92202933 |
48 | MP0002269_muscular_atrophy | 1.91528802 |
49 | MP0005666_abnormal_adipose_tissue | 1.89143994 |
50 | MP0002396_abnormal_hematopoietic_system | 1.88480447 |
51 | MP0005025_abnormal_response_to | 1.85953541 |
52 | MP0002405_respiratory_system_inflammati | 1.85808365 |
53 | MP0005387_immune_system_phenotype | 1.84935433 |
54 | MP0001790_abnormal_immune_system | 1.84935433 |
55 | MP0006035_abnormal_mitochondrial_morpho | 1.80113338 |
56 | MP0005083_abnormal_biliary_tract | 1.78378464 |
57 | MP0008877_abnormal_DNA_methylation | 1.74363752 |
58 | MP0000685_abnormal_immune_system | 1.73317005 |
59 | MP0002429_abnormal_blood_cell | 1.70908921 |
60 | MP0000749_muscle_degeneration | 1.70798756 |
61 | MP0001666_abnormal_nutrient_absorption | 1.70775806 |
62 | MP0005319_abnormal_enzyme/_coenzyme | 1.70188275 |
63 | MP0003221_abnormal_cardiomyocyte_apopto | 1.65289498 |
64 | MP0004087_abnormal_muscle_fiber | 1.64018177 |
65 | MP0000609_abnormal_liver_physiology | 1.62437113 |
66 | MP0000465_gastrointestinal_hemorrhage | 1.61885035 |
67 | MP0003786_premature_aging | 1.61568504 |
68 | MP0004043_abnormal_pH_regulation | 1.59971166 |
69 | MP0010155_abnormal_intestine_physiology | 1.59792572 |
70 | MP0002419_abnormal_innate_immunity | 1.58240270 |
71 | MP0002118_abnormal_lipid_homeostasis | 1.56562521 |
72 | MP0003186_abnormal_redox_activity | 1.56038136 |
73 | MP0000750_abnormal_muscle_regeneration | 1.55143661 |
74 | MP0005310_abnormal_salivary_gland | 1.51790134 |
75 | MP0002006_tumorigenesis | 1.50693843 |
76 | MP0008775_abnormal_heart_ventricle | 1.49395948 |
77 | MP0008260_abnormal_autophagy | 1.49077165 |
78 | MP0002148_abnormal_hypersensitivity_rea | 1.46536781 |
79 | MP0005266_abnormal_metabolism | 1.45512997 |
80 | MP0009643_abnormal_urine_homeostasis | 1.42962767 |
81 | MP0001544_abnormal_cardiovascular_syste | 1.41443272 |
82 | MP0005385_cardiovascular_system_phenoty | 1.41443272 |
83 | MP0001764_abnormal_homeostasis | 1.40644823 |
84 | MP0008995_early_reproductive_senescence | 1.39183276 |
85 | MP0010630_abnormal_cardiac_muscle | 1.39175315 |
86 | MP0002972_abnormal_cardiac_muscle | 1.37035418 |
87 | MP0000747_muscle_weakness | 1.34728734 |
88 | MP0003705_abnormal_hypodermis_morpholog | 1.34585441 |
89 | MP0003137_abnormal_impulse_conducting | 1.30768714 |
90 | MP0001845_abnormal_inflammatory_respons | 1.30425852 |
91 | MP0004019_abnormal_vitamin_homeostasis | 1.28224939 |
92 | MP0006138_congestive_heart_failure | 1.27927709 |
93 | MP0008058_abnormal_DNA_repair | 1.27385387 |
94 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26576165 |
95 | MP0004233_abnormal_muscle_weight | 1.26339343 |
96 | MP0003787_abnormal_imprinting | 1.25661113 |
97 | MP0002277_abnormal_respiratory_mucosa | 1.25615877 |
98 | MP0002971_abnormal_brown_adipose | 1.24414113 |
99 | MP0004185_abnormal_adipocyte_glucose | 1.21128516 |
100 | MP0005620_abnormal_muscle_contractility | 1.20166830 |
101 | MP0002019_abnormal_tumor_incidence | 1.19123991 |
102 | MP0008961_abnormal_basal_metabolism | 1.18539776 |
103 | MP0004947_skin_inflammation | 1.18470701 |
104 | MP0005464_abnormal_platelet_physiology | 1.15800268 |
105 | MP0000372_irregular_coat_pigmentation | 1.15502676 |
106 | MP0002106_abnormal_muscle_physiology | 1.14527710 |
107 | MP0000015_abnormal_ear_pigmentation | 1.10722635 |
108 | MP0002933_joint_inflammation | 1.10092136 |
109 | MP0003191_abnormal_cellular_cholesterol | 1.09468414 |
110 | MP0003693_abnormal_embryo_hatching | 1.07155565 |
111 | MP0001851_eye_inflammation | 1.07084016 |
112 | MP0002078_abnormal_glucose_homeostasis | 1.06316014 |
113 | MP0002163_abnormal_gland_morphology | 1.05916393 |
114 | MP0004957_abnormal_blastocyst_morpholog | 1.04497529 |
115 | MP0005375_adipose_tissue_phenotype | 1.04066081 |
116 | MP0001853_heart_inflammation | 1.01514038 |
117 | MP0000490_abnormal_crypts_of | 0.97397807 |
118 | MP0003656_abnormal_erythrocyte_physiolo | 0.96519813 |
119 | MP0000598_abnormal_liver_morphology | 0.95569764 |
120 | MP0005636_abnormal_mineral_homeostasis | 0.91108077 |
121 | MP0000759_abnormal_skeletal_muscle | 0.90275347 |
122 | MP0009697_abnormal_copulation | 0.89830633 |
123 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89324434 |
124 | MP0003828_pulmonary_edema | 0.88631321 |
125 | MP0002332_abnormal_exercise_endurance | 0.87532438 |
126 | MP0001661_extended_life_span | 0.87076976 |
127 | MP0001730_embryonic_growth_arrest | 0.85449364 |
128 | MP0005369_muscle_phenotype | 0.85151070 |
129 | MP0003868_abnormal_feces_composition | 0.85046052 |
130 | MP0005376_homeostasis/metabolism_phenot | 0.84529445 |
131 | MP0004808_abnormal_hematopoietic_stem | 0.84206025 |
132 | MP0003300_gastrointestinal_ulcer | 0.82873245 |
133 | MP0006082_CNS_inflammation | 0.82565723 |
134 | MP0005451_abnormal_body_composition | 0.82435802 |
135 | MP0008469_abnormal_protein_level | 0.80616330 |
136 | MP0002127_abnormal_cardiovascular_syste | 0.80023001 |
137 | MP0002102_abnormal_ear_morphology | 0.79684982 |
138 | MP0004484_altered_response_of | 0.77714515 |
139 | MP0004147_increased_porphyrin_level | 0.77682115 |
140 | MP0005535_abnormal_body_temperature | 0.77636053 |
141 | MP0000358_abnormal_cell_content/ | 0.77202507 |
142 | MP0001533_abnormal_skeleton_physiology | 0.77199927 |
143 | MP0004085_abnormal_heartbeat | 0.76568382 |
144 | MP0002138_abnormal_hepatobiliary_system | 0.76495554 |
145 | MP0003984_embryonic_growth_retardation | 0.75555426 |
146 | MP0002970_abnormal_white_adipose | 0.74905761 |
147 | MP0002088_abnormal_embryonic_growth/wei | 0.74289058 |
148 | MP0005408_hypopigmentation | 0.73717210 |
149 | MP0002095_abnormal_skin_pigmentation | 0.73705313 |
150 | MP0005379_endocrine/exocrine_gland_phen | 0.72530085 |
151 | MP0010094_abnormal_chromosome_stability | 0.72174295 |
152 | MP0001756_abnormal_urination | 0.71909689 |
153 | MP0003718_maternal_effect | 0.70191857 |
154 | MP0003111_abnormal_nucleus_morphology | 0.69242749 |
155 | MP0001986_abnormal_taste_sensitivity | 0.68946798 |
156 | MP0005334_abnormal_fat_pad | 0.68442601 |
157 | MP0001672_abnormal_embryogenesis/_devel | 0.68163039 |
158 | MP0005380_embryogenesis_phenotype | 0.68163039 |
159 | MP0009765_abnormal_xenobiotic_induced | 0.68141327 |
160 | MP0009672_abnormal_birth_weight | 0.67059407 |
161 | MP0000427_abnormal_hair_cycle | 0.65395091 |
162 | MP0009642_abnormal_blood_homeostasis | 0.64745916 |
163 | MP0004145_abnormal_muscle_electrophysio | 0.64325266 |
164 | MP0001929_abnormal_gametogenesis | 0.64031338 |
165 | MP0000313_abnormal_cell_death | 0.63510094 |
166 | MP0003077_abnormal_cell_cycle | 0.62363313 |
167 | MP0001663_abnormal_digestive_system | 0.61566510 |
168 | MP0009763_increased_sensitivity_to | 0.61560934 |
169 | MP0004142_abnormal_muscle_tone | 0.61537057 |
170 | MP0005174_abnormal_tail_pigmentation | 0.60580955 |
171 | MP0004883_abnormal_blood_vessel | 0.60544968 |
172 | MP0002132_abnormal_respiratory_system | 0.60103410 |
173 | MP0000266_abnormal_heart_morphology | 0.59677295 |
174 | MP0008873_increased_physiological_sensi | 0.58755781 |
175 | MP0002998_abnormal_bone_remodeling | 0.58126043 |
176 | MP0003950_abnormal_plasma_membrane | 0.56314429 |
177 | MP0001697_abnormal_embryo_size | 0.54414228 |
178 | MP0002080_prenatal_lethality | 0.54217896 |
179 | MP0005220_abnormal_exocrine_pancreas | 0.54209974 |
180 | MP0000230_abnormal_systemic_arterial | 0.50017977 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 7.12498149 |
2 | Abnormality of T cell number (HP:0011839) | 6.54181283 |
3 | Hypoglycemic coma (HP:0001325) | 5.01242006 |
4 | Hyperglycinuria (HP:0003108) | 4.93617154 |
5 | Abnormality of T cells (HP:0002843) | 4.81689230 |
6 | Hyperammonemia (HP:0001987) | 4.50270736 |
7 | Myoglobinuria (HP:0002913) | 4.48712617 |
8 | Severe combined immunodeficiency (HP:0004430) | 4.47114969 |
9 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.45572793 |
10 | Abnormality of glycine metabolism (HP:0010895) | 4.45572793 |
11 | Ketosis (HP:0001946) | 4.39208525 |
12 | Stomatitis (HP:0010280) | 4.36275054 |
13 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.25433804 |
14 | Hyperglycinemia (HP:0002154) | 4.23472274 |
15 | Ketoacidosis (HP:0001993) | 4.20815618 |
16 | IgG deficiency (HP:0004315) | 4.20249645 |
17 | IgM deficiency (HP:0002850) | 4.19719013 |
18 | Intrahepatic cholestasis (HP:0001406) | 4.14892578 |
19 | Dicarboxylic aciduria (HP:0003215) | 4.06891102 |
20 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.06891102 |
21 | Rhabdomyolysis (HP:0003201) | 4.05900723 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.04770535 |
23 | Autoimmune hemolytic anemia (HP:0001890) | 4.01707251 |
24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.88811025 |
25 | Cerebral edema (HP:0002181) | 3.87841637 |
26 | Combined immunodeficiency (HP:0005387) | 3.76379198 |
27 | Hepatic necrosis (HP:0002605) | 3.76343784 |
28 | Recurrent fungal infections (HP:0002841) | 3.72289248 |
29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.65739994 |
30 | Panhypogammaglobulinemia (HP:0003139) | 3.61844079 |
31 | Hypobetalipoproteinemia (HP:0003563) | 3.61608858 |
32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.59804514 |
33 | Pustule (HP:0200039) | 3.58951199 |
34 | Eczematoid dermatitis (HP:0000976) | 3.49050693 |
35 | Acute encephalopathy (HP:0006846) | 3.47162277 |
36 | Xanthomatosis (HP:0000991) | 3.42578586 |
37 | Abnormality of eosinophils (HP:0001879) | 3.42149631 |
38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.37558026 |
39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.37558026 |
40 | Recurrent bacterial skin infections (HP:0005406) | 3.36589413 |
41 | Sudden death (HP:0001699) | 3.34288392 |
42 | Lethargy (HP:0001254) | 3.33093113 |
43 | Increased serum pyruvate (HP:0003542) | 3.30322634 |
44 | Abnormality of glycolysis (HP:0004366) | 3.30322634 |
45 | Abnormality of serum amino acid levels (HP:0003112) | 3.26998645 |
46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26540974 |
47 | Deep venous thrombosis (HP:0002625) | 3.26411923 |
48 | Palpitations (HP:0001962) | 3.25167263 |
49 | Exercise-induced muscle cramps (HP:0003710) | 3.24274927 |
50 | Generalized aminoaciduria (HP:0002909) | 3.22879105 |
51 | Thyroiditis (HP:0100646) | 3.19413422 |
52 | Abnormality of T cell physiology (HP:0011840) | 3.16884259 |
53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.16200318 |
54 | Myositis (HP:0100614) | 3.16140793 |
55 | Hypoplasia of the thymus (HP:0000778) | 3.15956939 |
56 | IgA deficiency (HP:0002720) | 3.15432261 |
57 | Metabolic acidosis (HP:0001942) | 3.13715973 |
58 | Gout (HP:0001997) | 3.12623030 |
59 | Hypolipoproteinemia (HP:0010981) | 3.12288452 |
60 | Recurrent viral infections (HP:0004429) | 3.10893197 |
61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.10664932 |
62 | Ventricular tachycardia (HP:0004756) | 3.10234815 |
63 | Leukocytosis (HP:0001974) | 3.04551778 |
64 | Acute necrotizing encephalopathy (HP:0006965) | 3.00689317 |
65 | Eosinophilia (HP:0001880) | 2.97297938 |
66 | Hepatocellular necrosis (HP:0001404) | 2.97202622 |
67 | Proximal tubulopathy (HP:0000114) | 2.94740894 |
68 | Lactic acidosis (HP:0003128) | 2.94316937 |
69 | Hypoalphalipoproteinemia (HP:0003233) | 2.93966282 |
70 | Encephalitis (HP:0002383) | 2.91201263 |
71 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.89724411 |
72 | Lymphopenia (HP:0001888) | 2.88950341 |
73 | Recurrent abscess formation (HP:0002722) | 2.88389387 |
74 | Increased muscle lipid content (HP:0009058) | 2.86150977 |
75 | Granulocytopenia (HP:0001913) | 2.85579792 |
76 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.84444104 |
77 | Exercise-induced myalgia (HP:0003738) | 2.83927056 |
78 | Ragged-red muscle fibers (HP:0003200) | 2.83245079 |
79 | Optic neuritis (HP:0100653) | 2.81017872 |
80 | Retrobulbar optic neuritis (HP:0100654) | 2.81017872 |
81 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79220105 |
82 | Hyperlipoproteinemia (HP:0010980) | 2.78786626 |
83 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.76385338 |
84 | Nausea (HP:0002018) | 2.76240812 |
85 | Recurrent bronchitis (HP:0002837) | 2.71335445 |
86 | Increased CSF lactate (HP:0002490) | 2.70548471 |
87 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.67897694 |
88 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.66813886 |
89 | Increased IgM level (HP:0003496) | 2.61817291 |
90 | Basal cell carcinoma (HP:0002671) | 2.61509117 |
91 | Muscle fiber splitting (HP:0003555) | 2.60620387 |
92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59923719 |
93 | Abnormality of alanine metabolism (HP:0010916) | 2.59923719 |
94 | Hyperalaninemia (HP:0003348) | 2.59923719 |
95 | Abnormality of purine metabolism (HP:0004352) | 2.59112045 |
96 | Recurrent skin infections (HP:0001581) | 2.57027849 |
97 | Hyperuricemia (HP:0002149) | 2.56757198 |
98 | Increased purine levels (HP:0004368) | 2.56757198 |
99 | Gastrointestinal infarctions (HP:0005244) | 2.54933592 |
100 | Lymphoma (HP:0002665) | 2.53972086 |
101 | Vomiting (HP:0002013) | 2.53624909 |
102 | Lipoatrophy (HP:0100578) | 2.50851388 |
103 | Stomach cancer (HP:0012126) | 2.48988438 |
104 | Abnormality of methionine metabolism (HP:0010901) | 2.47322066 |
105 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46632462 |
106 | Right ventricular cardiomyopathy (HP:0011663) | 2.44232868 |
107 | Mitochondrial inheritance (HP:0001427) | 2.44051493 |
108 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.43597899 |
109 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.43597899 |
110 | Delayed CNS myelination (HP:0002188) | 2.41130004 |
111 | Dilated cardiomyopathy (HP:0001644) | 2.40565016 |
112 | Aplastic anemia (HP:0001915) | 2.40340492 |
113 | Progressive macrocephaly (HP:0004481) | 2.40181368 |
114 | Keratoconjunctivitis sicca (HP:0001097) | 2.38944072 |
115 | Multiple enchondromatosis (HP:0005701) | 2.38586207 |
116 | Abnormality of the fingertips (HP:0001211) | 2.38046282 |
117 | Abnormality of chromosome stability (HP:0003220) | 2.37491837 |
118 | Acute hepatic failure (HP:0006554) | 2.37312025 |
119 | Meningitis (HP:0001287) | 2.36756806 |
120 | Keratoconjunctivitis (HP:0001096) | 2.36666994 |
121 | Calf muscle hypertrophy (HP:0008981) | 2.36580538 |
122 | Increased serum lactate (HP:0002151) | 2.35954353 |
123 | Inflammation of the large intestine (HP:0002037) | 2.35336709 |
124 | Abnormality of B cell number (HP:0010975) | 2.34787707 |
125 | Vasculitis (HP:0002633) | 2.34491082 |
126 | Hyperbilirubinemia (HP:0002904) | 2.34049957 |
127 | Abnormal gallbladder morphology (HP:0012437) | 2.33921940 |
128 | Cholelithiasis (HP:0001081) | 2.32990487 |
129 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32504086 |
130 | Hypoglycemic seizures (HP:0002173) | 2.32347497 |
131 | Colitis (HP:0002583) | 2.32007585 |
132 | Mediastinal lymphadenopathy (HP:0100721) | 2.30641277 |
133 | Atrioventricular block (HP:0001678) | 2.30209185 |
134 | Prolonged partial thromboplastin time (HP:0003645) | 2.29388413 |
135 | Hyperglycemia (HP:0003074) | 2.28348023 |
136 | CNS demyelination (HP:0007305) | 2.25622500 |
137 | Chronic diarrhea (HP:0002028) | 2.25441683 |
138 | Epidermoid cyst (HP:0200040) | 2.25014552 |
139 | Respiratory failure (HP:0002878) | 2.23144221 |
140 | Abnormal spermatogenesis (HP:0008669) | 2.22936458 |
141 | Orchitis (HP:0100796) | 2.22874593 |
142 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.21673295 |
143 | Methylmalonic aciduria (HP:0012120) | 2.19849176 |
144 | Late onset (HP:0003584) | 2.19311857 |
145 | Abnormality of urine glucose concentration (HP:0011016) | 2.17917291 |
146 | Glycosuria (HP:0003076) | 2.17917291 |
147 | Gastrointestinal inflammation (HP:0004386) | 2.15603821 |
148 | Spastic diplegia (HP:0001264) | 2.11277896 |
149 | Atrial fibrillation (HP:0005110) | 2.10577181 |
150 | Renal cortical cysts (HP:0000803) | 2.09615206 |
151 | Autoimmune thrombocytopenia (HP:0001973) | 2.09447089 |
152 | Obstructive lung disease (HP:0006536) | 2.08672359 |
153 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08672359 |
154 | Exercise intolerance (HP:0003546) | 2.07812732 |
155 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.07006513 |
156 | Progressive muscle weakness (HP:0003323) | 2.06955913 |
157 | Hyporeflexia of lower limbs (HP:0002600) | 2.05474755 |
158 | Complement deficiency (HP:0004431) | 2.05103521 |
159 | Skin nodule (HP:0200036) | 2.04699089 |
160 | Periodontitis (HP:0000704) | 2.02942777 |
161 | Abnormal cartilage morphology (HP:0002763) | 2.02821678 |
162 | Fat malabsorption (HP:0002630) | 2.02284629 |
163 | Cellular immunodeficiency (HP:0005374) | 2.01973229 |
164 | Verrucae (HP:0200043) | 2.00981084 |
165 | Papilloma (HP:0012740) | 2.00981084 |
166 | Slow saccadic eye movements (HP:0000514) | 1.98929625 |
167 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.95555054 |
168 | Anorexia (HP:0002039) | 1.95532876 |
169 | Abnormal hair whorl (HP:0010721) | 1.90092156 |
170 | Lipid accumulation in hepatocytes (HP:0006561) | 1.87551920 |
171 | Hemoptysis (HP:0002105) | 1.87326713 |
172 | Chest pain (HP:0100749) | 1.85953823 |
173 | Hypochromic microcytic anemia (HP:0004840) | 1.84978377 |
174 | 3-Methylglutaconic aciduria (HP:0003535) | 1.82295558 |
175 | Neutropenia (HP:0001875) | 1.82149066 |
176 | Myelodysplasia (HP:0002863) | 1.77597583 |
177 | Prolonged bleeding time (HP:0003010) | 1.77250420 |
178 | Fatigue (HP:0012378) | 1.77234499 |
179 | Abnormality of DNA repair (HP:0003254) | 1.75503578 |
180 | Spontaneous hematomas (HP:0007420) | 1.75127007 |
181 | B lymphocytopenia (HP:0010976) | 1.73351794 |
182 | Clubbing of toes (HP:0100760) | 1.70788591 |
183 | Respiratory difficulties (HP:0002880) | 1.70223483 |
184 | Prominent nose (HP:0000448) | 1.69160270 |
185 | Papillary thyroid carcinoma (HP:0002895) | 1.68522133 |
186 | Gingival bleeding (HP:0000225) | 1.67671062 |
187 | Bronchitis (HP:0012387) | 1.66067908 |
188 | Abnormality of the prostate (HP:0008775) | 1.65349062 |
189 | Keratitis (HP:0000491) | 1.65108577 |
190 | Joint swelling (HP:0001386) | 1.65105075 |
191 | Volvulus (HP:0002580) | 1.61125176 |
192 | Pulmonary infiltrates (HP:0002113) | 1.58239837 |
193 | Agammaglobulinemia (HP:0004432) | 1.56603939 |
194 | Epistaxis (HP:0000421) | 1.56428385 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 5.67849634 |
2 | BCKDK | 5.65077533 |
3 | PDK4 | 4.50673802 |
4 | PDK3 | 4.50673802 |
5 | MAP4K1 | 4.11584332 |
6 | NEK1 | 3.74183321 |
7 | PKN2 | 3.48326393 |
8 | TAOK3 | 3.20406752 |
9 | TTN | 3.14263741 |
10 | TRIB3 | 2.84570844 |
11 | PDK2 | 2.79337124 |
12 | CAMKK2 | 2.67786276 |
13 | GRK6 | 2.58624208 |
14 | ITK | 2.46132494 |
15 | IKBKE | 2.29406297 |
16 | NLK | 2.26781389 |
17 | LMTK2 | 2.06658715 |
18 | BTK | 2.01961806 |
19 | TEC | 1.98643303 |
20 | TYK2 | 1.97728930 |
21 | MYLK | 1.95555094 |
22 | FLT3 | 1.92334401 |
23 | STK38L | 1.86770258 |
24 | EIF2AK1 | 1.86371709 |
25 | OBSCN | 1.84517880 |
26 | WEE1 | 1.81811157 |
27 | BUB1 | 1.78187020 |
28 | JAK3 | 1.77810955 |
29 | FES | 1.74892699 |
30 | SYK | 1.74761049 |
31 | MARK3 | 1.67880777 |
32 | PHKG1 | 1.67562297 |
33 | PHKG2 | 1.67562297 |
34 | LCK | 1.63106093 |
35 | ZAP70 | 1.62560479 |
36 | RIPK4 | 1.61995870 |
37 | NME2 | 1.59132864 |
38 | PIK3CG | 1.58613400 |
39 | SIK1 | 1.51063087 |
40 | JAK1 | 1.45446834 |
41 | PIM1 | 1.43396780 |
42 | TTK | 1.41692122 |
43 | BLK | 1.39571316 |
44 | CSK | 1.35653304 |
45 | EPHA2 | 1.35623883 |
46 | NUAK1 | 1.34345838 |
47 | WNK4 | 1.29506947 |
48 | MAP3K14 | 1.29249319 |
49 | HCK | 1.27798502 |
50 | PINK1 | 1.20978352 |
51 | MUSK | 1.19453722 |
52 | TSSK6 | 1.19008215 |
53 | BRD4 | 1.13793816 |
54 | PRKCQ | 1.13618707 |
55 | CDK4 | 1.11661143 |
56 | ERN1 | 1.10573310 |
57 | LYN | 1.07422558 |
58 | LATS1 | 1.06948974 |
59 | NEK2 | 1.04898679 |
60 | ERBB4 | 1.03807076 |
61 | ACVR1B | 1.03615747 |
62 | CDC7 | 1.02749443 |
63 | SRPK1 | 1.01065744 |
64 | CAMKK1 | 0.99656479 |
65 | KDR | 0.95999815 |
66 | EIF2AK3 | 0.95973586 |
67 | MAP3K13 | 0.94884871 |
68 | MAPK11 | 0.92197484 |
69 | IKBKB | 0.91950387 |
70 | CLK1 | 0.91942548 |
71 | SIK3 | 0.91926856 |
72 | SGK2 | 0.91459850 |
73 | FGFR4 | 0.90971123 |
74 | PRKAA1 | 0.90759793 |
75 | FGFR3 | 0.90731438 |
76 | NEK9 | 0.87921404 |
77 | TNIK | 0.86831296 |
78 | ZAK | 0.86616351 |
79 | MST4 | 0.85668036 |
80 | BRSK2 | 0.85415363 |
81 | STK4 | 0.83412612 |
82 | IRAK4 | 0.83191835 |
83 | PASK | 0.83155958 |
84 | ILK | 0.81948808 |
85 | INSRR | 0.79250889 |
86 | WNK3 | 0.78539226 |
87 | STK24 | 0.78238399 |
88 | SCYL2 | 0.78178941 |
89 | TLK1 | 0.77245860 |
90 | PAK3 | 0.76775273 |
91 | CCNB1 | 0.73030232 |
92 | MELK | 0.72998414 |
93 | NEK6 | 0.70965357 |
94 | PRKAA2 | 0.69941731 |
95 | DYRK3 | 0.68605357 |
96 | MAPKAPK3 | 0.67599456 |
97 | FGR | 0.67358899 |
98 | CAMK4 | 0.67115512 |
99 | PTK6 | 0.66924791 |
100 | RPS6KB2 | 0.66192703 |
101 | CDK12 | 0.65290672 |
102 | AURKB | 0.65042888 |
103 | PLK1 | 0.63985391 |
104 | PAK4 | 0.61818416 |
105 | EEF2K | 0.61019154 |
106 | PRPF4B | 0.60540462 |
107 | FRK | 0.57114418 |
108 | MAP3K10 | 0.56535830 |
109 | ABL2 | 0.56352488 |
110 | RAF1 | 0.56035260 |
111 | LRRK2 | 0.55366000 |
112 | MAP3K5 | 0.55347971 |
113 | PIK3CA | 0.55211280 |
114 | TESK2 | 0.55183746 |
115 | MAP3K8 | 0.54386514 |
116 | AKT2 | 0.53692330 |
117 | SIK2 | 0.53356642 |
118 | CSF1R | 0.53122292 |
119 | MTOR | 0.53085679 |
120 | TBK1 | 0.52822841 |
121 | BMPR2 | 0.49812168 |
122 | PDK1 | 0.49607008 |
123 | STK3 | 0.48857393 |
124 | CDK6 | 0.48621976 |
125 | AURKA | 0.48511606 |
126 | MAP2K2 | 0.47269185 |
127 | NME1 | 0.47016610 |
128 | STK16 | 0.46708702 |
129 | EGFR | 0.45977250 |
130 | MAP2K3 | 0.45600310 |
131 | SGK3 | 0.43629639 |
132 | GRK5 | 0.43027171 |
133 | RPS6KA5 | 0.42691069 |
134 | WNK1 | 0.42090401 |
135 | ERBB3 | 0.42071218 |
136 | PLK4 | 0.41404516 |
137 | TIE1 | 0.41240280 |
138 | BRSK1 | 0.40775138 |
139 | MAP4K2 | 0.39825984 |
140 | VRK1 | 0.39691746 |
141 | MAP3K3 | 0.39079700 |
142 | MAP3K7 | 0.38401315 |
143 | CHUK | 0.38286270 |
144 | LATS2 | 0.37248129 |
145 | PRKACG | 0.37231058 |
146 | MAPK12 | 0.36723424 |
147 | DAPK3 | 0.36236181 |
148 | ATM | 0.35734246 |
149 | DYRK1B | 0.34729357 |
150 | CSNK2A2 | 0.33916025 |
151 | BMPR1B | 0.33599165 |
152 | YES1 | 0.33239045 |
153 | ATR | 0.33059040 |
154 | SGK223 | 0.32744118 |
155 | SGK494 | 0.32744118 |
156 | SGK1 | 0.32468375 |
157 | FGFR1 | 0.32413856 |
158 | EPHA3 | 0.31154002 |
159 | ICK | 0.30678132 |
160 | CDK7 | 0.30617914 |
161 | PRKCI | 0.30429622 |
162 | CAMK2D | 0.30330059 |
163 | STK10 | 0.30081784 |
164 | CHEK1 | 0.29999190 |
165 | TRIM28 | 0.29965399 |
166 | PRKD1 | 0.29302977 |
167 | STK38 | 0.28032913 |
168 | MET | 0.27685915 |
169 | PRKACB | 0.27309082 |
170 | AKT3 | 0.25392248 |
171 | JAK2 | 0.24955249 |
172 | DMPK | 0.24947840 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.26978477 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.97797423 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.58427013 |
4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.45692032 |
5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.30187776 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26891806 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.14033235 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.13513914 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.00237377 |
10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.96542768 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.50116651 |
12 | Measles_Homo sapiens_hsa05162 | 2.48018675 |
13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.42144266 |
14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.40262241 |
15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.37255260 |
16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.33388453 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21836530 |
18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16251920 |
19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.13233947 |
20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.11625175 |
21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.06750883 |
22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.06484751 |
23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.05445819 |
24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.99808224 |
25 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.98770918 |
26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.94689827 |
27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.93408428 |
28 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90403653 |
29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89992476 |
30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.88787022 |
31 | Allograft rejection_Homo sapiens_hsa05330 | 1.86383894 |
32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84891601 |
33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76396730 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.75867324 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71891176 |
36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.70337802 |
37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66620784 |
38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66500218 |
39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61208327 |
40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57854714 |
41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57722836 |
42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57494661 |
43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53416309 |
44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52772967 |
45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.52171562 |
46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.51211029 |
47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48802826 |
48 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.43165149 |
49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42453864 |
50 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.40676071 |
51 | Leishmaniasis_Homo sapiens_hsa05140 | 1.38483046 |
52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35744885 |
53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.34520642 |
54 | Homologous recombination_Homo sapiens_hsa03440 | 1.33078148 |
55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31646076 |
56 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30444452 |
57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.29580264 |
58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26199997 |
59 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20774572 |
60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20343280 |
61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.19794387 |
62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.18448730 |
63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18188139 |
64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.16720141 |
65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16498058 |
66 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14160459 |
67 | Cell cycle_Homo sapiens_hsa04110 | 1.10994981 |
68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.10796712 |
69 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.10402097 |
70 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10093156 |
71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.08634858 |
72 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.08621016 |
73 | Hepatitis B_Homo sapiens_hsa05161 | 1.07050448 |
74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.06637494 |
75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06276519 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.04724682 |
77 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02102350 |
78 | Apoptosis_Homo sapiens_hsa04210 | 0.99751538 |
79 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99303407 |
80 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97930590 |
81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97265109 |
82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.96830282 |
83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.96410383 |
84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96154803 |
85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95642733 |
86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94554590 |
87 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93975221 |
88 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.92488713 |
89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.91398248 |
90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91164657 |
91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90899301 |
92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.90126303 |
93 | Legionellosis_Homo sapiens_hsa05134 | 0.90102338 |
94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89718046 |
95 | Lysine degradation_Homo sapiens_hsa00310 | 0.89596547 |
96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89565936 |
97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.89067216 |
98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87183266 |
99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86678750 |
100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86570440 |
101 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86562566 |
102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85966221 |
103 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85134736 |
104 | Influenza A_Homo sapiens_hsa05164 | 0.84377530 |
105 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82821331 |
106 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82151171 |
107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81072844 |
108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81072038 |
109 | Proteasome_Homo sapiens_hsa03050 | 0.75997837 |
110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75164675 |
111 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.74299905 |
112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73521940 |
113 | Bile secretion_Homo sapiens_hsa04976 | 0.73376575 |
114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71004088 |
115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70436183 |
116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70376118 |
117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69858330 |
118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68455109 |
119 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68146603 |
120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67901168 |
121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66662439 |
122 | Tuberculosis_Homo sapiens_hsa05152 | 0.66551344 |
123 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66492952 |
124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65989500 |
125 | DNA replication_Homo sapiens_hsa03030 | 0.65759745 |
126 | Platelet activation_Homo sapiens_hsa04611 | 0.64712897 |
127 | Hepatitis C_Homo sapiens_hsa05160 | 0.63947878 |
128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63616966 |
129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62797406 |
130 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62104808 |
131 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.61313514 |
132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.57172488 |
133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54123911 |
134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53080835 |
135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52784346 |
136 | Mismatch repair_Homo sapiens_hsa03430 | 0.52013754 |
137 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50815221 |
138 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50656704 |
139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49008399 |
140 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48877715 |
141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47793329 |
142 | RNA transport_Homo sapiens_hsa03013 | 0.45813866 |
143 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45630402 |
144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44602613 |
145 | RNA polymerase_Homo sapiens_hsa03020 | 0.44084526 |
146 | Malaria_Homo sapiens_hsa05144 | 0.44051456 |
147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42645605 |
148 | Insulin resistance_Homo sapiens_hsa04931 | 0.42450837 |
149 | ABC transporters_Homo sapiens_hsa02010 | 0.41588421 |
150 | Prostate cancer_Homo sapiens_hsa05215 | 0.37293416 |
151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36224505 |
152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36214342 |
153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33513248 |
154 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31909489 |
155 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31155742 |
156 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.28344264 |
157 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25349946 |
158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.24100541 |
159 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.23987003 |
160 | Purine metabolism_Homo sapiens_hsa00230 | 0.23536443 |
161 | Ribosome_Homo sapiens_hsa03010 | 0.22910368 |
162 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21256768 |
163 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.19484067 |
164 | Base excision repair_Homo sapiens_hsa03410 | 0.17910733 |
165 | Spliceosome_Homo sapiens_hsa03040 | 0.17157782 |
166 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.16279163 |
167 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.15193355 |
168 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.15184219 |
169 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.14441751 |
170 | RNA degradation_Homo sapiens_hsa03018 | 0.11708377 |